Caplin Point Laboratories Hits Day Low of Rs 2020 Amid Price Pressure

Caplin Point Laboratories has experienced a significant decline today, with the stock dropping by 7.22% as of September 26, 2025. The stock reached an intraday low of Rs 2020, reflecting a decrease of 7.35%. This downturn marks the second consecutive day of losses for the small-cap pharmaceutical company, which has seen a total decline of 10.57% over this period. In comparison to the broader market, Caplin Point Laboratories underperformed, falling 4.81% below its sector average. The Pharmaceuticals & Drugs sector itself has also faced challenges, with a decline of 2.37%. Caplin Point Laboratories is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend in its short to long-term performance. Over the past week, the stock has decreased by 14.16%, while its performance over the past month shows a decline of 3.50%. Despite these recent challenges, the stock has shown a positive performance of 4.79% over the past year, contrasting with the Sensex's decline of 6.30% during the same period.